Details of the Drug

General Information of Drug (ID: DMMGK2B)

Drug Name
4-Butoxy-N-hydroxycarbamoylmethyl-benzamide
Synonyms CHEMBL371715; 4-Butoxy-N-hydroxycarbamoylmethyl-benzamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 266.29
Logarithm of the Partition Coefficient (xlogp) 1.3
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C13H18N2O4
IUPAC Name
4-butoxy-N-[2-(hydroxyamino)-2-oxoethyl]benzamide
Canonical SMILES
CCCCOC1=CC=C(C=C1)C(=O)NCC(=O)NO
InChI
InChI=1S/C13H18N2O4/c1-2-3-8-19-11-6-4-10(5-7-11)13(17)14-9-12(16)15-18/h4-7,18H,2-3,8-9H2,1H3,(H,14,17)(H,15,16)
InChIKey
BFVCLRFRELSADQ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44404479
ChEBI ID
CHEMBL371715
TTD ID
D01QOB
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Matrix metalloproteinase-1 (MMP-1) TTMX39J MMP1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Receptor flexibility in de novo ligand design and docking. J Med Chem. 2005 Oct 20;48(21):6585-96.